Please assess the completion status of the following clinical trial:

Trial Title: Aldosterone Blockade in Chronic Kidney Disease: Influence on Arterial Stiffness and Kidney Function

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ≥ 18 years age ≤ 80 years age~* voluntarily signed informed consent~* 15 ml/min/1,73 m2 ≤ estimated Glomerular Filtration Rate \< 60 ml/min/1,73 m2~* BP ≥ 130/80 mmHg or undergoing anti-hypertensive treatment~Exclusion Criteria:~* p-potassium is \> 5.0 mM~* allergy to contents~* treated with spironolactone~* treated with potent inhibitors of CYP3A4 (see SPC for details)~* treated with lithium, ciclosporin, tacrolimus, prednisolone, or other immunosuppressing drug~* inborn errors of metabolism (see SPC for details)~* pregnancy or lactation~* fertile woman, not using safe contraception devices~* dementia or other psychiatric disorder, making understanding of the study conditions impossible~* other severe, chronic illness besides CKD, including liver insufficiency, according to investigators' judgement~* vascular surgery including stenting or graft implantation on a. brachialis, aorta or the carotid arteries~* systolic BP \> 200 mmHg~* immeasurable pulse amplitude

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Treatment (Type: ACTIVE_COMPARATOR): None
- Control (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).